Needham & Company Starts OncoGenex Pharmaceuticals (OGXI) at Buy; Significantly Undervalued; Robust Pipeline

Go back to Needham & Company Starts OncoGenex Pharmaceuticals (OGXI) at Buy; Significantly Undervalued; Robust Pipeline
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $2.80 
Open $0.05    52 Week Low $0.33 
Day High $0.40    P/E N/A 
Day Low $0.40    EPS $-1.98 
Volume 500